LIGHTINTHEBOX HOLDING-ADR (LITB)

US53225G2012 - ADR

1.09  -0.17 (-13.49%)

Fundamental Rating

1

Overall LITB gets a fundamental rating of 1 out of 10. We evaluated LITB against 32 industry peers in the Broadline Retail industry. LITB may be in some trouble as it scores bad on both profitability and health. LITB has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

LITB had negative earnings in the past year.
LITB had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LITB reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: LITB reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -7.66%, LITB is doing worse than 77.42% of the companies in the same industry.
Industry RankSector Rank
ROA -7.66%
ROE N/A
ROIC N/A
ROA(3y)-11.74%
ROA(5y)-5.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LITB's Gross Margin of 57.18% is fine compared to the rest of the industry. LITB outperforms 77.42% of its industry peers.
LITB's Gross Margin has improved in the last couple of years.
LITB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.92%
GM growth 5Y16.28%

1

2. Health

2.1 Basic Checks

LITB does not have a ROIC to compare to the WACC, probably because it is not profitable.
LITB has about the same amout of shares outstanding than it did 1 year ago.
LITB has more shares outstanding than it did 5 years ago.
There is no outstanding debt for LITB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

LITB has an Altman-Z score of 1.92. This is not the best score and indicates that LITB is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.92, LITB perfoms like the industry average, outperforming 48.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.92
ROIC/WACCN/A
WACC9.43%

2.3 Liquidity

LITB has a Current Ratio of 0.64. This is a bad value and indicates that LITB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of LITB (0.64) is worse than 96.77% of its industry peers.
LITB has a Quick Ratio of 0.64. This is a bad value and indicates that LITB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.60, LITB is not doing good in the industry: 83.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.6

1

3. Growth

3.1 Past

The earnings per share for LITB have decreased strongly by -112.50% in the last year.
LITB shows a decrease in Revenue. In the last year, the revenue decreased by -9.67%.
LITB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.01% yearly.
EPS 1Y (TTM)-112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.67%
Revenue growth 3Y0.01%
Revenue growth 5YN/A
Sales Q2Q%-51.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

LITB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LITB!.
Industry RankSector Rank
Dividend Yield N/A

LIGHTINTHEBOX HOLDING-ADR

NYSE:LITB (1/14/2025, 8:04:00 PM)

1.09

-0.17 (-13.49%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-26 2024-11-26/bmo
Earnings (Next)03-24 2025-03-24
Inst Owners7.63%
Inst Owner Change0%
Ins Owners12.06%
Ins Owner ChangeN/A
Market Cap121.17M
Analysts43.33
Price TargetN/A
Short Float %0.23%
Short Ratio5.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS5.66
BVpS-0.08
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.66%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.18%
FCFM N/A
ROA(3y)-11.74%
ROA(5y)-5.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.92%
GM growth 5Y16.28%
F-Score5
Asset Turnover4.98
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.17%
Cap/Sales 0.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.6
Altman-Z 1.92
F-Score5
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)39.36%
Cap/Depr(5y)62.56%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.67%
Revenue growth 3Y0.01%
Revenue growth 5YN/A
Sales Q2Q%-51.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-162.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-157.81%
OCF growth 3YN/A
OCF growth 5YN/A